Apyx Medical (APYX)
(Delayed Data from NSDQ)
$1.96 USD
-0.08 (-3.92%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $1.87 -0.09 (-4.59%) 5:32 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
Currently, Apyx Medical Corporation has a PEG ratio of 2.55 compared to the Medical - Products industry's PEG ratio of 1.56.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
APYX 1.96 -0.08(-3.92%)
Will APYX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APYX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APYX
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Apyx Medical (APYX) Reports Q3 Loss, Lags Revenue Estimates
APYX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Evolus, Inc. (EOLS) Reports Q3 Loss, Misses Revenue Estimates
Apyx (APYX) Upgraded to Buy: Here's What You Should Know
Reasons to Retain Revvity Stock in Your Portfolio for Now
Other News for APYX
Apyx Medical Corp Reports Q2 2025 Earnings: EPS Loss of $0.09 Beats Estimates, Revenue at $11. ...
Apyx Medical GAAP EPS of $0.09 beats by $0.18, revenue of $11.4M misses by $0.3M
Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and ...
Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | APYX ...
Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference ...